Sutterella Inhibition of Aryl hydrocarbon receptor Interleukin-22 signaling and worsening of intestinal inflammation byspecies.
Researchers identify a gut microbe (Sutterella species) that may worsen intestinal inflammation by blocking AhR-driven IL-22 and IL-17 responses—pathways that help protect the gut lining.
For people with IBD, this helps explain how certain bacteria could influence disease activity and points toward microbiome-targeted research.
Researchers studying the microbiome or immune mechanisms in IBD, clinicians interested in microbiome influences on disease, and patients who follow microbiome research.
What To Know
What To Know This study reports that a gut bacterium in the Sutterella genus can act as a pathobiont that reduces production of IL-22 and IL-17 from lymphoid cells and worsens inflammation in a mouse (DSS-colitis) model.
The paper says Sutterella secretes protein-based factors that antagonize aryl hydrocarbon receptor (AhR) signaling, which is linked to reduced IL-22/IL-17 responses. The experiments described include ex vivo and in vivo work and tests on human lymphoid cells showing similar reductions in IL-22/IL-17.
The authors propose this mechanism could help explain how microbiota members influence intestinal inflammation and suggest it could point to new therapeutic strategies. This is an abstract-level report of basic science research published in a peer-reviewed journal.
It describes mechanisms in experimental models rather than clinical trials or treatments, so it does not provide clinical recommendations or established therapies.
This classification is based on the article abstract and partial extracted text from the journal Gut Microbes. Findings are from experimental (mouse and ex vivo human cell) work; they do not report clinical trials or patient-treatment results. Further research is needed to translate these mechanisms into therapies.
